James W. Stave
Corporate Officer/Principal at CD Diagnostics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Richard C. Birkmeyer | M | - |
CD Diagnostics, Inc.
 CD Diagnostics, Inc. BiotechnologyHealth Technology CD Diagnostics, Inc. provides research and development about joint fluid. It is developing a series of immunoassays to detect the cause of joint pain using joint fluid. The firm's immunoassay is a test that measures the presence of a substance. The company was founded by Carl Deirmengian and Michael J. Behr in 2008 and is headquartered in Claymont, DE. | - |
| Carl Deirmengian | M | - |
CD Diagnostics, Inc.
CD Diagnostics, Inc. BiotechnologyHealth Technology CD Diagnostics, Inc. provides research and development about joint fluid. It is developing a series of immunoassays to detect the cause of joint pain using joint fluid. The firm's immunoassay is a test that measures the presence of a substance. The company was founded by Carl Deirmengian and Michael J. Behr in 2008 and is headquartered in Claymont, DE. | 16 years |
| Robert E. Booth | M | - |
CD Diagnostics, Inc.
CD Diagnostics, Inc. BiotechnologyHealth Technology CD Diagnostics, Inc. provides research and development about joint fluid. It is developing a series of immunoassays to detect the cause of joint pain using joint fluid. The firm's immunoassay is a test that measures the presence of a substance. The company was founded by Carl Deirmengian and Michael J. Behr in 2008 and is headquartered in Claymont, DE. | - |
| Anne Cavanaugh | F | - |
CD Diagnostics, Inc.
CD Diagnostics, Inc. BiotechnologyHealth Technology CD Diagnostics, Inc. provides research and development about joint fluid. It is developing a series of immunoassays to detect the cause of joint pain using joint fluid. The firm's immunoassay is a test that measures the presence of a substance. The company was founded by Carl Deirmengian and Michael J. Behr in 2008 and is headquartered in Claymont, DE. | - |
| Connie Viering | F | - |
CD Diagnostics, Inc.
CD Diagnostics, Inc. BiotechnologyHealth Technology CD Diagnostics, Inc. provides research and development about joint fluid. It is developing a series of immunoassays to detect the cause of joint pain using joint fluid. The firm's immunoassay is a test that measures the presence of a substance. The company was founded by Carl Deirmengian and Michael J. Behr in 2008 and is headquartered in Claymont, DE. | - |
| Nat C. Brinn | M | - |
CD Diagnostics, Inc.
CD Diagnostics, Inc. BiotechnologyHealth Technology CD Diagnostics, Inc. provides research and development about joint fluid. It is developing a series of immunoassays to detect the cause of joint pain using joint fluid. The firm's immunoassay is a test that measures the presence of a substance. The company was founded by Carl Deirmengian and Michael J. Behr in 2008 and is headquartered in Claymont, DE. | 12 years |
| Alan Davis | M | - |
CD Diagnostics, Inc.
CD Diagnostics, Inc. BiotechnologyHealth Technology CD Diagnostics, Inc. provides research and development about joint fluid. It is developing a series of immunoassays to detect the cause of joint pain using joint fluid. The firm's immunoassay is a test that measures the presence of a substance. The company was founded by Carl Deirmengian and Michael J. Behr in 2008 and is headquartered in Claymont, DE. | - |
| Katarzyna Mazur-Hofsaess | M | 60 |
CD Diagnostics, Inc.
CD Diagnostics, Inc. BiotechnologyHealth Technology CD Diagnostics, Inc. provides research and development about joint fluid. It is developing a series of immunoassays to detect the cause of joint pain using joint fluid. The firm's immunoassay is a test that measures the presence of a substance. The company was founded by Carl Deirmengian and Michael J. Behr in 2008 and is headquartered in Claymont, DE. | - |
| Keith W. Kardos | M | - |
CD Diagnostics, Inc.
CD Diagnostics, Inc. BiotechnologyHealth Technology CD Diagnostics, Inc. provides research and development about joint fluid. It is developing a series of immunoassays to detect the cause of joint pain using joint fluid. The firm's immunoassay is a test that measures the presence of a substance. The company was founded by Carl Deirmengian and Michael J. Behr in 2008 and is headquartered in Claymont, DE. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Matthew Monaghan | M | 56 |
CD Diagnostics, Inc.
CD Diagnostics, Inc. BiotechnologyHealth Technology CD Diagnostics, Inc. provides research and development about joint fluid. It is developing a series of immunoassays to detect the cause of joint pain using joint fluid. The firm's immunoassay is a test that measures the presence of a substance. The company was founded by Carl Deirmengian and Michael J. Behr in 2008 and is headquartered in Claymont, DE. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 10 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- James W. Stave
- Personal Network
